Pharmaceutical Sciences (PSC)

Danté Johnson Receives 14th Annual Graduate Translational Research Award from UM Ventures at UMB

April 7, 2022

UMSOP PhD candidate helped develop an innovative method for automated analysis of the higher order structure of proteins in biological models, allowing for complex in vivo drug design and modeling.

PSC Faculty Members Receive $2.5 Million from NIAID to Study Multi-drug Resistant Bacteria

March 7, 2022

Two pharmaceutical sciences professors are collaborating to research the regulation of heme utilization in Pseudomonas aeruginosa.

MacKerell Honored with American Chemical Society Award

January 12, 2022

Grollman-Glick Professor of Pharmaceutical Sciences recognized for work on use of computers in chemical and pharmaceutical research.

Minding the ABC’s of Complex Generic Drugs: Access, Bioequivalence, and Complexity

January 1, 2022

New center strives to help develop generics and patients who need them

PSC Faculty Member Receives Inaugural MPower Professorship

December 9, 2021

Bruce Yu, PhD, is one of eight professors from the University of Maryland, Baltimore and the University of Maryland, College Park awarded $150,000 each over three years.

Probiotic-Containing Yogurt Protects Against Microbiome Changes That Lead to Antibiotic-Induced Diarrhea, Study Finds

September 15, 2021

Multi-Disciplinary Team of Researchers – Including UMSOP’s Mass Spectrometry Experts – Identify Mechanism of Protection Conferred by Probiotic Supplement

PSC Faculty Member Receives $1.9 Million MIRA Award from the NIH

September 10, 2021

Five-year grant supports research on nanoparticles’ design on inflammatory responses

UMSOP and KamTek Collaborate on Therapeutic Development to Treat Deadly Infections

November 23, 2020

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.

Grant Increases Access, Safety of Generic Drugs

September 29, 2020

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

M-CERSI Workshop Spotlights 3D Cell Culture Models for Drug PK, Safety, and Efficacy Assessment

September 22, 2020

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

SOP Researchers Make Progress Toward Antiviral Treatments for COVID-19

September 16, 2020

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

CERSI Conference Spotlights Latest Advances in Topical Drug Development

August 24, 2020

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.